Ignite Creation Date:
2024-05-06 @ 12:54 AM
Last Modification Date:
2024-10-26 @ 10:56 AM
Study NCT ID:
NCT01683188
Status:
TERMINATED
Last Update Posted:
2021-02-01
First Post:
2012-09-07
Brief Title:
HD IL-2 Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Sponsor:
Clinigen Inc
Organization:
Clinigen Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-08
Start Date Type:
None
Primary Completion Date:
2014-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-11
Completion Date Type:
ACTUAL
First Submit Date:
2012-09-07
First Submit QC Date:
September 7 2012
Study First Post Date:
2012-09-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-28
Last Update Post Date:
2021-02-01
Last Update Post Date Type:
ACTUAL